Indication

Acute coronary syndrome

Acute coronary syndrome is an umbrella term for a continuum of life-threatening cardiovascular conditions caused by an abrupt reduction in blood flow through the coronary arteries, leading to acute myocardial ischemia or infarction. Read more about Acute coronary syndrome

224 drugs 152 manufacturers

Advertisement

Drugs that treat it

Common Acute coronary syndrome therapies.

Showing 10–18 of 224 drugs

BRILINTA (ticagrelor)

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW·MYOCARDIAL REINFARCTION PREVENTION·+4
AstraZeneca Pharmaceuticals

ASPIRIN

ACUTE MYOCARDIAL INFARCTION·+16
MEDIQUE PRODUCT
Filter & compare in the drug finder →Opens the drug finder with Acute coronary syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute coronary syndrome.

Acute coronary syndrome is an umbrella term for a continuum of life-threatening cardiovascular conditions caused by an abrupt reduction in blood flow through the coronary arteries, leading to acute myocardial ischemia or infarction.

Primarily affecting adults with underlying coronary artery disease, it encompasses unstable angina, non–ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction.

Pathophysiologically, the syndrome is most commonly precipitated by atherosclerotic plaque disruption—such as rupture or superficial erosion—followed by platelet activation and thrombosis, leading to partial or total vascular occlusion.

Clinically, it presents with ischemic symptoms, classic electrocardiographic alterations, and varying degrees of myocardial necrosis evidenced by elevated cardiac biomarkers such as troponin.

Personalize your experience

Follow Acute coronary syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it